RESUMEN
Castleman disease (CD), a distinct lymphoproliferative disorder, is infrequently encountered in clinical practice and poses significant diagnostic challenges. We present the case of a 48-year-old asymptomatic female, admitted for evaluation of a hepatic mass detected in the liver's right lobe. Preoperative laboratory tests were within normal limits. Diagnostic imaging, including contrast-enhanced magnetic resonance imaging (MRI), was suggestive of hepatocellular carcinoma. Furthermore, contrast-enhanced abdominal computed tomography (CT) scans were indicative of hepatic malignancy. Subsequently, the patient underwent laparoscopic surgery targeting a retroperitoneal mass. During the surgical procedure, it was observed that the tumor was a retroperitoneal mass situated posterior to the liver, exhibiting localized adhesion to hepatic tissue. The postoperative histopathological analysis revealed the mass to be hyaline-vascular type Castleman disease (HV-CD), thereby refuting the initial diagnosis of a hepatic malignancy. This case underscores the complexity of diagnosing retroperitoneal Castleman disease, particularly when it masquerades as a hepatic tumor.
RESUMEN
The streams of waste gases containing NO from industries would cause seriously pollution on the environment if they are directly discharged without further purification. The property of removal of NO from the waste gas at lower temperature performed on platinum catalyst by reduction with NH3 was investigated. Experimental study showed that the precious catalyst, platinum, had good activity at low temperature and high selectivity of catalytic removal of NO from the waste gas by ammonia. However, its performance was affected by the sulfur compound, SO2, which was present in the waste gas. Results indicated that the performance of platinum supported catalyst could be improved with addition of lanthanides on it. The suitable compositions of the modified catalyst were 1:3.78:3.56 molar ratio of Pt:La:Ce in the experiment.
